HCV ANTIBODY AVIDITY–BASED METHOD TO ESTIMATE POPULATION-LEVEL INCIDENCE
Accurate hepatitis C virus (HCV) incidence estimates are critical for monitoring progress towards hepatitis C elimination goals which include a reduction in HCV incidence of 80% by 2030. Moreover, incidence estimates can help guide local prevention and treatment programming, particularly in the context of the US opioid epidemic. An inexpensive ($4/sample), Genedia-based HCV IgG antibody…